NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Issue 854 coverTOWARDS PROLONGATION OF THE HEALTHY LIFE SPAN: Practical Approaches to Intervention Copyright © 1998 by the New York Academy of Sciences
description

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via HighWire
Citing Articles via Google Scholar
Google Scholar
Articles by REDDEL, R. R.
Search for Related Content
PubMed
PubMed Citation
Articles by REDDEL, R. R.
Annals of the New York Academy of Sciences 854:8-19 (1998)
© 1998 New York Academy of Sciences

Genes Involved in the Control of Cellular Proliferative Potentiala

ROGER R. REDDELb

Children's Medical Research Institute, 214 Hawkesbury Road, Westmead, Sydney, NSW 2145, Australia

aWork in this laboratory has been supported by the Carcinogenesis Fellowship of the NSW Cancer Council and project Grants from the National Health and Medical Research Council of Australia.
bAddress for correspondence: Roger R. Reddel, Children's Medical Research Institute, Locked Bag 23, Wentworthville, NSW 2145, Australia. Tel.: +61-2-9687-2800; fax: +61-2-9687-2120; e-mail: rreddel{at}cmri.usyd.edu.au

Evidence that control of cellular proliferative potential may be linked to telomere length, along with data indicating that other factors may also be involved, will be reviewed. According to the telomere hypothesis of senescence, the sequential loss of telomeric repeat DNA that occurs during the replication of normal somatic cells eventually dictates the onset of the permanently nonreplicative state known as senescence. Many immortalized cells express telomerase, a ribonucleoprotein enzyme that replaces the telomeric DNA that would otherwise be lost due to replication. However, some immortalized human cells may avoid telomeric shortening without using telomerase. The mechanism involved is currently unknown, but other eukaryotes are able to replace telomeric DNA through (1) recombination and copy switching or (2) retrotransposition. Human fibroblasts that lose p53 function proliferate a limited number of times beyond the population-doubling level at which their normal counterparts become senescent. Lack of functional retinoblastoma (Rb) protein (or equivalent events, such as loss of p16INK4 function, resulting in abrogation of Rb regulatory activity) also permits a temporary extension of proliferative potential. The p53 and pRb effects are additive, indicating that they exert their control on proliferative potential separately. The temporary life span extension associated with loss of p53 and/or Rb pathway function is accompanied by continued telomere shortening. The proliferation arrest that eventually ensues in p53-minus cells or in p53-minus/Rb-minus cells may be regarded as terminal proliferation arrest states serving as a backup to senescence. p53-minus/Rb-minus cells cannot proliferate further unless they acquire the ability to prevent telomeric shortening. Somatic cell hybridization and microcell-mediated chromosome transfer experiments indicate that immortalization involves the loss of function of other, as yet unidentified, genes; some of these may normally repress telomerase expression in somatic cells.




This article has been cited by other articles:


Home page
Ann. N. Y. Acad. Sci.Home page
M. KANATSU-SHINOHARA and T. SHINOHARA
Culture and Genetic Modification of Mouse Germline Stem Cells
Ann. N.Y. Acad. Sci., December 1, 2007; 1120(1): 59 - 71.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Li, J. Lu, and E. V. Prochownik
c-Myc-mediated genomic instability proceeds via a megakaryocytic endomitosis pathway involving Gp1b{alpha}
PNAS, February 27, 2007; 104(9): 3490 - 3495.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
S. Kamoshida, H. Matsuoka, T. Ishikawa, K. Maeda, R. Shimomura, K.-i. Inada, and Y. Tsutsumi
Immunohistochemical Evaluation of Thymidylate Synthase (TS) and p16INK4a in Advanced Colorectal Cancer: Implication of TS Expression in 5-FU-based Adjuvant Chemotherapy
Jpn. J. Clin. Oncol., October 1, 2004; 34(10): 594 - 601.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. P. Dimri, J.-L. Martinez, J. J. L. Jacobs, P. Keblusek, K. Itahana, M. van Lohuizen, J. Campisi, D. E. Wazer, and V. Band
The Bmi-1 Oncogene Induces Telomerase Activity and Immortalizes Human Mammary Epithelial Cells
Cancer Res., August 15, 2002; 62(16): 4736 - 4745.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Z. Wang, R. Yu, and S. Melmed
Mice Lacking Pituitary Tumor Transforming Gene Show Testicular and Splenic Hypoplasia, Thymic Hyperplasia, Thrombocytopenia, Aberrant Cell Cycle Progression, and Premature Centromere Division
Mol. Endocrinol., November 1, 2001; 15(11): 1870 - 1879.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
D P O'Connor, E W Kay, M Leader, G M Murphy, G J Atkins, and M J E M F Mabruk
A high degree of chromosomal instability at 13q14 in cutaneous squamous cell carcinomas: indication for a role of a tumour suppressor gene other than Rb
Mol. Pathol., June 1, 2001; 54(3): 165 - 169.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
D. C. Danila, X. Zhang, Y. Zhou, G. R. Dickersin, J. A. Fletcher, E. T. Hedley-Whyte, M. K. Selig, S. R. Johnson, and A. Klibanski
A Human Pituitary Tumor-Derived Folliculostellate Cell Line
J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1180 - 1187.
[Abstract] [Full Text]


Home page
FASEB J.Home page
J.-P. LIU
Studies of the molecular mechanisms in the regulation of telomerase activity
FASEB J, December 1, 1999; 13(15): 2091 - 2104.
[Abstract] [Full Text]



footerLeft footerRight